Mixed Methods Assessment of Exercises for Knee OA

May 23, 2016 updated by: Jimmy Molyneux, University of Salford

Mixed Methods Study to Evaluate Pain, Function, Postural Stabilisation, and Fear of Movement Following a Lower Limb Exercise Programme for Knee Osteoarthritis

Osteoarthritis (OA) is a condition that causes cartilage loss, bony remodeling, joint stiffness and generalized muscle weakness. 90% of OA presentation has been reported within the leg; with 44% affecting the knee joint. Knee OA is expected to increase by 50% over the next twenty years due to an ageing population, obesity, and societal trends such as lack of activity. Only 13% of knee OA sufferers reach the recommended levels of exercise therefore an understanding of how psychological and functional relationships effect exercise engagement, which in turn would provide a more comprehensive rehabilitation programme for patients with knee OA. The aim of this study is to investigate exercise in knee OA and it it's correlation with fear of movement, using a mixed methods approach. Quantitative methodology will investigate lower limb exercises for pain and function and fear of movement. The desired outcome of the study will show that a reduction in pain with patient specific exercise will also reduce the fear of movement and allow patients to self-manage their symptoms without fear. Other quantitative factors such as intensity of exercise and postural stabilization using the Y balance test will also be utilized to review the functional relationship of muscle strength and balance to kinesiophobia. A semi-structured interview will be completed at the end of the course of treatment to highlight what patients think about exercise as an intervention. Participants aged forty-five and above with specific clinical symptoms will be invited into the study and will be asked to attend eight exercise sessions within a class environment, which will last for 1 hour within the Physiotherapy Department.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Exercise is recommended for the treatment for knee osteoarthritis (OA) with muscle strength and aerobic exercise improving physical function. There is evidence supporting quadriceps strength for patients with painful knee OA; positive effects on pain; and general fitness.

Research reviews by suggest exercise as an important aspect of rehabilitation in knee OA. However, there is very limited evidence to what type of exercises actually decrease pain and improve activity.

Despite positive evidence regarding exercise, highlighted major issues within the United Kingdom with only 5% of people with knee OA achieving the recommended level of activity and 57% of the population not completing regular exercise. 1% to 4% of total healthcare costs account for physical inactivity which cost 8.3 billion in 2009.

An essential factor of physical inactivity is exercise behaviour. Fear of movement is an important aspect of knee OA. Disability is present due to the individual's fear of physical movements that would cause pain. Evidence links fear of movement with knee OA and the role of exercise in the management of knee OA. Patients with OA experience pain during activity, which leads to an expectation that further activity, will cause greater pain therefore increasing muscle weakness. It has been indicated that individuals could have negative attitudes and beliefs about their knee problems, which could cause a barrier to treatment, with socioeconomic, personality and environmental factors being as important as the physical characteristics. Other factors such as balance issues and laxity of the knee have been associated with activity limitations. However, in a systematic review found weak evidence to support pain, distress, and avoidance of activity in participants with knee OA. Understanding individual exercise behaviours and habits is essential to improve exercise adherence. Non-compliance is common within physiotherapy with patients unwilling to accommodate exercises within everyday life. Reasons for this may include type of exercises, dosage, and underlying beliefs from the clinicians towards exercise as well as external factors. Incorrect prescription of exercises can lead to increased pain, decreased function and decreased exercise adherence. This could cause fear of movement whilst completing exercise. It has been concluded that in OA there is limited evidence that interventions can improve exercise adherence. Therefore, an understanding of non-adherence and the effects of kinesiophobia is essential to further develop exercise programmes for patients with OA.

Study Type

Interventional

Enrollment (Anticipated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leigh, United Kingdom, wn7 1hs
        • Recruiting
        • Bridgewater Community Healthcare Foundation Trust
        • Contact:
        • Contact:
        • Principal Investigator:
          • Jimmy Molyneux, MSc
        • Sub-Investigator:
          • Ben Riley, BSc
        • Sub-Investigator:
          • Richard Jones, Professor
        • Sub-Investigator:
          • Lee Herrington, Dr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Patients must elicit 3 of the 6 symptoms to be included:

  • forty five years of age and over.
  • stiffness for less than thirty minutes;
  • crepitus;
  • bony tenderness;
  • bony enlargement;
  • no palpable joint warmth.

Exclusion Criteria:

  • previous lower limb joint injection within three months;
  • previous hip or knee joint replacement;
  • any severe cognitive, cardio- respiratory, musculoskeletal or neurological - diagnosis that prevents participants from exercising;
  • insoles or braces;
  • ligament instability;
  • participants with a body mass index (BMI) over 40 will be issued with a choice of completing in the study or being managed by the National Health Service weight management service;
  • other minor health related issues will be assessed prior to the commencement of the study to ensure safe practice.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Exercise, Kinesiophobia and Knee Osteoarthritis
Participants will be asked to attend eight exercise sessions within a group class environment that will last for 1 hour. During the hour, participants will complete a 5 minute warm up followed by 14 exercises specific to strengthening the lower limb and improve aerobic capacity. Each exercise will be timed for two minutes with the participant reporting number of repetitions counted.
Participants will be asked to attend eight exercise sessions within a group class environment that will last for 1 hour. The exercise programme has been developed through clinical and research evidence. During the hour, a 5 minute warm up followed by 14 exercises specific to strengthening the lower limb and improving aerobic capacity. Each exercise will be timed for two minutes with the participant reporting number of repetitions counted. A cool down will be completed at the end of the class. After each exercise class, the participant will be advised to have a recovery day to prevent overloading (De Carlo & Armstrong, 2010). Progression of exercises will be patient led. Participants will attend twice per week for four weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the level of kinesiophobia with exercise assessed using the Tampa Kinesiophobia Scale during an exercise programme and 6 weeks after the programme.
Time Frame: At the beginning, through study completion, an average 10 weeks.
Patients will be asked to complete the Tampa Kinesiophobia Scale at the beginning of the study, before exercise session 4, before session 8 and 6 weeks after the exercise programme. This will measure the level of kinesiophobia associated with exercise. If an individual scores highly, this indicates a high level of kinesiophobia.
At the beginning, through study completion, an average 10 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the level of psychological and functional relationships using the Y balance test during an exercises programme and 6 weeks after the programme.
Time Frame: At the beginning, through study completion, an average 10 weeks.
The Y balance test is a quick, efficient, objective, portable, and consistent tool and will be used to evaluate dynamic and asymmetrical balance whilst utilising muscle strength and flexibility at the hip, knee and ankle joints. It consists of a stance platform to which three pieces of plastic pipe are attached in the three reach directions; anterior (ANT), posteromedial (PM), and posterolateral (PL). The PM and PL pipes are positioned 135 degrees from the ANT pipe with 45 degrees between the posterior pipes. The pipes are marked at 5 mm intervals for measurement. To perform the test the subject pushes the reach indicator along each of the pipes and a score is calculated. Each leg will be tested.
At the beginning, through study completion, an average 10 weeks.
Change in the understanding of key factors that patients think about exercise as an intervention using a semistructured interview.
Time Frame: 6 weeks post exercise class
A semi-structured interview will be completed at the end of course of treatment to highlight what patients think about exercise as an intervention.
6 weeks post exercise class

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the level of function, pain,quality of life, sport and recreation, activities of daily living and symptoms in patients during an exercise programme and 6 weeks after the programme.
Time Frame: At the beginning, through study completion, an average 10 weeks.
Knee injury and Osteoarthritis Outcome Score (KOOS) is a valid, highly reliable, and responsive for evaluating changes after OA interventions. This is a questionnaire that consists of 42 questions covering Pain; Symptoms; Function in Daily Living Function in Sport and Recreation and Knee-Related Quality of Life. The score is then normalized to a 0-100 scale with the higher score being better.
At the beginning, through study completion, an average 10 weeks.
Change in the level of physical activity during an exercise programme and 6 weeks after the programme.
Time Frame: At the beginning, through study completion, an average 10 weeks.
Physical activity will be measured using the physical activity scale for the elderly (PASE), which is a valid and reliable measurement tool. It is a self-administered questionnaire, which assesses a wide range of activities such as leisure time activity, household activity, and work related activity. It consists of 12 questions and is calculated by multiplying either the time spent in each activity (hours per week) or participation in an activity. The overall scores ranges' from 0-400.
At the beginning, through study completion, an average 10 weeks.
Change in the distance walked within a 6 minute period during an exercise programme and 6 weeks after the programme.
Time Frame: At the beginning, through study completion, an average 10 weeks.
A 6 minute walk test to assess aerobic walking capacity; dynamic balance whilst changing direction and maximal distance covered in a 6-minute period.
At the beginning, through study completion, an average 10 weeks.
Change in the level of pain intensity during an exercise programme and 6 weeks after the programme.
Time Frame: At the beginning, through study completion, an average 10 weeks.
Visual Analogue Scale (VAS) is an horizontal line, 100 mm in length, anchored by word descriptors at each end. The patient marks on the line the point that they feel represents their perception of their current pain intensity. The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks.
At the beginning, through study completion, an average 10 weeks.
Change in the level of perceived exertion during an exercise programme .
Time Frame: At the beginning, through study completion, an average 4 weeks.
Modified Borg scale for exercise intensity tool will be used. It will be used to document the patient's exertion after the exercise programme and is used to assess the intensity of training. The exertion is rated on a scale of 6-20, where 6 means "no exertion at all" and 20 means "maximal exertion.
At the beginning, through study completion, an average 4 weeks.
Change in the level of physical activity during an exercise programme and 6 weeks after the programme.
Time Frame: At the beginning and 6 weeks after the exercise programme.
An activity monitor will be issued to monitor physical activity and should be worn continuously for 7 days during waking hours. The Activity monitor is a device that measures the postural aspect of inactivity. It is a small monitor that is placed on the midline anterior aspect of the upper thigh and can determine body position, such as sitting, lying, being upright and movements between these postures, stepping and stepping speed.
At the beginning and 6 weeks after the exercise programme.
Change in the level of lower extremity functional strength during an exercise programme and 6 weeks after the programme.
Time Frame: At the beginning, through study completion, an average 10 weeks.

The 30 second chair test is administered using a folding chair without arms, with seat height of 17 inches (43.2 cm). The chair, with rubber tips on the legs, is placed against a wall to prevent it from moving.

The participant is seated in the middle of the chair, back straight; feet approximately shoulder width apart and placed on the floor at an angle slightly back from the knees, with one foot slightly in front of the other to help maintain balance. Arms are crossed at the wrists and held against the chest. The participant is encouraged to complete as many full stands as possible within 30 seconds. The participant is instructed to fully sit between each stand.The 30 second chair stand involves recording the number of stands a person can complete in 30 seconds.

At the beginning, through study completion, an average 10 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (ANTICIPATED)

April 1, 2017

Study Completion (ANTICIPATED)

April 1, 2017

Study Registration Dates

First Submitted

February 15, 2016

First Submitted That Met QC Criteria

April 5, 2016

First Posted (ESTIMATE)

April 12, 2016

Study Record Updates

Last Update Posted (ESTIMATE)

May 24, 2016

Last Update Submitted That Met QC Criteria

May 23, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • IRAS ID 154227

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The results of the study will form part of the researcher's doctoral thesis and may be published anonymously in professional journals and/or as conference presentations.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on exercise

Subscribe